0

Journal Articles

in Infectious Diseases and Global Health
 1-20 of 257 Articles
Original Contribution |  May 01, 2013
Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women:  A Randomized Clinical Trial
Simon R. M. Dobson, MD; Shelly McNeil, MD; Marc Dionne, MD; et al.
JAMA. 2013;309(17):1793-1802. doi:10.1001/jama.2013.1625.
INCLUDES: , Supplemental Content
Original Contribution |  May 01, 2013
Association Between Efavirenz-Based Compared With Nevirapine-Based Antiretroviral Regimens and Virological Failure in HIV-Infected Children
Elizabeth D. Lowenthal, MD, MSCE; Jonas H. Ellenberg, PhD; Edwin Machine, MPH; et al.
JAMA. 2013;309(17):1803-1809. doi:10.1001/jama.2013.3710.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  April 24, 2013
IOM Report Advises Shift in Focus for Next Phase of US AIDS Relief Program
Anita Slomski
JAMA. 2013;309(16):1672-1673. doi:10.1001/jama.2013.3394.
From JAMA's Daily News Site |  April 10, 2013
Selections From News@JAMA and JAMA Forum
JAMA. 2013;309(14):1451. doi:10.1001/jama.2013.3159.
Lab Reports |  April 03, 2013
Estimating Pandemic Threats
Tracy Hampton, PhD
JAMA. 2013;309(13):1337. doi:10.1001/jama.2013.3158.
Medical News and Perspectives |  March 20, 2013
South Africa Warns of Emergence of “Totally” Drug-Resistant Tuberculosis
Anita Slomski
JAMA. 2013;309(11):1097-1098. doi:10.1001/jama.2013.1802.
Global Health |  March 20, 2013
Epilepsy Risks in Africa
M. J. Friedrich
JAMA. 2013;309(11):1101. doi:10.1001/jama.2013.1828.
Global Health |  March 20, 2013
Control of River Blindness
M. J. Friedrich
JAMA. 2013;309(11):1101. doi:10.1001/jama.2013.2398.
Global Health |  March 20, 2013
Killings in Nigeria
M. J. Friedrich
JAMA. 2013;309(11):1101. doi:10.1001/jama.2013.2400.
From the Centers for Disease Control and Prevention |  March 20, 2013 FREE
Serogroup A Meningococcal Conjugate Vaccine Coverage After the First National Mass Immunization Campaign—Burkina Faso, 2011
JAMA. 2013;309(11):1104-1106. doi:10.1001/jama.2013.225.
Global Health |  February 20, 2013
Anti-Polio Campaign Reboot
M. J. Friedrich
JAMA. 2013;309(7):649. doi:10.1001/jama.2013.1019.
Medical News and Perspectives |  February 13, 2013
Indian Public Health Leaders Move to Reduce Antimicrobial Resistance
Mike Mitka, MSJ
JAMA. 2013;309(6):531-532. doi:10.1001/jama.2013.297.
Medical News and Perspectives |  February 13, 2013
US Longevity Falls Short vs That of Peer Countries
Bridget M. Kuehn, MSJ
JAMA. 2013;309(6):534. doi:10.1001/jama.2013.475.
Original Contribution |  February 13, 2013
Risk of Recurrent Helicobacter pylori Infection 1 Year After Initial Eradication Therapy in 7 Latin American Communities
Douglas R. Morgan, MD, MPH; Javier Torres, PhD; Rachael Sexton, MS; et al.
JAMA. 2013;309(6):578-586. doi:10.1001/jama.2013.311.
INCLUDES: , Supplemental Content
Review |  February 13, 2013
Intermittent Preventive Therapy for Malaria During Pregnancy Using 2 vs 3 or More Doses of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in Africa:  Systematic Review and Meta-analysis
Kassoum Kayentao, MD; Paul Garner, MD; Anne Maria van Eijk, PhD; et al.
JAMA. 2013;309(6):594-604. doi:10.1001/jama.2012.216231.
INCLUDES: CME , Supplemental Content
From the Centers for Disease Control and Prevention |  February 06, 2013
Expanding Poliomyelitis and Measles Surveillance Networks to Establish Surveillance for Acute Meningitis and Encephalitis Syndromes—Bangladesh, China, and India, 2006-2008
JAMA. 2013;309(5):434-436. doi:10.1001/jama.2012.217214.
Global Health |  January 16, 2013
HIV Drugs and Malaria
M. J. Friedrich
JAMA. 2013;309(3):223. doi:10.1001/jama.2012.206200.
From the Centers for Disease Control and Prevention |  January 09, 2013
Progress Toward Global Eradication of Dracunculiasis—January 2011- June 2012
JAMA. 2013;309(2):129-132. doi:10.1001/jama.2012.64610.
Global Health |  December 19, 2012
Polio Lingers in Pakistan
M. J. Friedrich
JAMA. 2012;308(23):2449. doi:10.1001/jama.2012.128610.
Global Health |  December 19, 2012
Experimental Malaria Vaccine
M. J. Friedrich
JAMA. 2012;308(23):2449. doi:10.1001/jama.2012.128613.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Clinical Trials  |  February 7, 2013
Can We Stop Mass Drug Administration Prior to 3 Annual Rounds in Communities With Low Prevalence of Trachoma?:  PRET Ziada Trial Results
Jithin Yohannan, BA; Beatriz Munoz, MS; Harran Mkocha, BS; et al.
JAMA Dermatology
Study  |  Nov 2012
Validation of a New International Quality-of-Life Instrument Specific to Cosmetics and Physical Appearance:  BeautyQoL Questionnaire
Ariel Beresniak, MD, MPH, PhD; Yolaine de Linares, MSc; Gerald G. Krueger, MD; et al.
JAMA Ophthalmology
Research Letters  |  Nov 2012
Novel Etiological Agent: Molecular Evidence for Trematode-Induced Anterior Uveitis in Children
Sivakumar R. Rathinam, FAMS, PhD; Lalan Kumar Arya, MSc; Kim R. Usha, MD; et al.
JAMA Ophthalmology
Small Case Series  |  Nov 2012
Live Juvenile Strobilate Tapeworm in the Anterior Chamber of the Human Eye
Gunjan Joshi, MD; Swapnil Parchand, MD; Mangat Ram Dogra, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems